Kirsten A Ward-Hartstonge (Kirsten Ward-Hartstonge)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Radiofrequency Ablation

Pluripotent Stem Cells

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Clinical & translational immunology

European journal of immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Caroline Lamarche, Kirsten A Ward-Hartstonge, Tian Mi, David T S Lin, Qing Huang, Andrew Brown, Karlie Edwards, Gherman E Novakovsky, Christopher N Qi, Michael S Kobor, Caitlin C Zebley, Evan W Weber, Crystal L Mackall, Megan K Levings
Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion. Proceedings of the National Academy of Sciences of the United States of America 120 (14) (2023)
Samuel E Norton, Tiffany Khong, Malarmathy Ramachandran, Andrew J Highton, Kirsten A Ward-Hartstonge, Jake Shortt, Andrew Spencer, Roslyn A Kemp
Changes in immune cell populations following KappaMab, lenalidomide and low-dose dexamethasone treatment in multiple myeloma. Clinical & translational immunology 12 (12) (2023)
Caroline Lamarche, Kirsten A Ward-Hartstonge, Tian Mi, David T S Lin, Qing Huang, Andrew Brown, Karlie Edwards, Gherman E Novakovsky, Christopher N Qi, Michael S Kobor, Caitlin C Zebley, Evan W Weber, Crystal L Mackall, Megan K Levings
Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion. Proceedings of the National Academy of Sciences of the United States of America 120 (14) (2023)
Avery J Lam, Manjurul Haque, Kirsten A Ward-Hartstonge, Prakruti Uday, Christine M Wardell, Jana K Gillies, Madeleine Speck, Majid Mojibian, Ramon I Klein Geltink, Megan K Levings
PTEN is required for human Treg suppression of costimulation in vitro. European journal of immunology 52 (9) (2022)